Cargando…

Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis

BACKGROUND: MET amplifications occur in human tumors, including non-small cell lung cancer (NSCLC). MET inhibitors have demonstrated some clinical activity in MET amplified NSCLC, presumably with a gene dose effect. However, the definition of MET positivity or MET amplification as a potential oncoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Overbeck, Tobias Raphael, Cron, Dana Alina, Schmitz, Katja, Rittmeyer, Achim, Körber, Wolfgang, Hugo, Sara, Schnalke, Juliane, Lukat, Laura, Hugo, Tabea, Hinterthaner, Marc, Reuter-Jessen, Kirsten, Rosenthal, Tessa, Moecks, Joachim, Bleckmann, Annalen, Schildhaus, Hans-Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354108/ https://www.ncbi.nlm.nih.gov/pubmed/32676323 http://dx.doi.org/10.21037/tlcr-19-339

Ejemplares similares

NTRK Gene Fusions in Non-Small-Cell Lung Cancer: Real-World Screening Data of 1068 Unselected Patients
por: Overbeck, Tobias Raphael, et al.
Publicado: (2023)

FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis
por: Fromme, Julia Elisabeth, et al.
Publicado: (2018)

Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer
por: Elakad, Omar, et al.
Publicado: (2020)

MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome
por: Yin, Wei, et al.
Publicado: (2022)

Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation
por: Bleckmann, Annalen, et al.
Publicado: (2020)

High MET gene copy number predicted poor prognosis in primary intestinal diffuse large B-cell lymphoma
por: Huang, Wan-Ting, et al.
Publicado: (2013)

Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome: A single-center retrospective analysis of 21 years’ practice
por: Guhlich, Manuel, et al.
Publicado: (2022)

MET Gene Copy Number Alterations and Expression of MET and Hepatocyte Growth Factor Are Potential Biomarkers in Angiosarcomas and Undifferentiated Pleomorphic Sarcomas
por: Schmitz, Katja, et al.
Publicado: (2015)

“SpezPat”- common advance directives versus disease-centred advance directives: a randomised controlled pilot study on the impact on physicians’ understanding of non-small cell lung cancer patients’ end-of-life decisions
por: Koenig, Julia Felicitas Leni, et al.
Publicado: (2022)

WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer
por: Menck, Kerstin, et al.
Publicado: (2021)

Monitoring of Diabetic Patients with Poor Glycemic Control. Are International Recommendations Met?
por: Delgado, José Antonio, et al.
Publicado: (2021)

ReadMax—a novel reading and scoring approach for EGFR gene copy number to predict therapeutic benefit of erlotinib treatment in EGFR wild‐type non‐small‐cell lung cancer
por: Moecks, Joachim, et al.
Publicado: (2015)

Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition
por: Kemper, Marcel, et al.
Publicado: (2021)

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition
por: Kemper, Marcel, et al.
Publicado: (2022)

β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases
por: Bleckmann, Annalen, et al.
Publicado: (2016)

Quality of Life in Patients with NSCLC Receiving Maintenance Therapy
por: Rittmeyer, Achim
Publicado: (2015)

MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection
por: Sakamoto, Naoko, et al.
Publicado: (2017)

MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer
por: Ko, Jihoon, et al.
Publicado: (2022)

Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
por: Li, Meihui, et al.
Publicado: (2021)

Coordination of Tongue Activity During Swallowing in Mouth-breathing Children
por: Knösel, Michael, et al.
Publicado: (2011)

Detection of Simultaneous Group Effects in MicroRNA Expression and Related Target Gene Sets
por: Artmann, Stephan, et al.
Publicado: (2012)

Microvesicles in Cancer: Small Size, Large Potential
por: Menck, Kerstin, et al.
Publicado: (2020)

The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention
por: Menck, Kerstin, et al.
Publicado: (2021)

The Poor and the Poor Law
Publicado: (1894)

Partial Response to First-Line Crizotinib in an Elderly Male Patient with ROS1 Translocation-Positive Lung Cancer
por: Overbeck, Tobias R., et al.
Publicado: (2016)

Increased Expression of c-Met is Associated with Chemotherapy-Resistant Breast Cancer and Poor Clinical Outcome
por: Jia, Lizhou, et al.
Publicado: (2018)

Copy number alteration signature defines undifferentiated pleomorphic sarcomas and leiomyosarcomas with poor prognosis
por: Silveira, Sara Martoreli, et al.
Publicado: (2013)

Why asthma might surprisingly protect against poor outcomes in COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

Decreasing child death from diarrhoea requires more focus on poor hygiene
por: Smeets, Hugo M, et al.
Publicado: (2020)

Predicting restoration of kidney function during CRRT-free intervals
por: Heise, Daniel, et al.
Publicado: (2012)

Isolation and Characterization of Microvesicles from Peripheral Blood
por: Menck, Kerstin, et al.
Publicado: (2017)

To treat or not to treat: A rare case of response to pembrolizumab‐based immunotherapy‐chemotherapy in non‐small cell lung cancer with acute liver failure due to multiple bile duct metastases
por: Shaforostova, Inna, et al.
Publicado: (2020)

Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors
por: Irmer, Barnabas, et al.
Publicado: (2023)

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines
por: Arriola, E, et al.
Publicado: (2011)

Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer
por: Madoz-Gúrpide, Juan, et al.
Publicado: (2015)

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis
por: Yamasaki, Koji, et al.
Publicado: (2018)

Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma
por: De Herdt, Maria J., et al.
Publicado: (2016)

Overexpression of c-Met is Associated with Poor Prognosis in Glioblastoma Multiforme: A Systematic Review and Meta-Analyses
por: Anton, Jellyca, et al.
Publicado: (2021)

Increased copy number of mitochondrial DNA predicts poor prognosis of esophageal squamous cell carcinoma
por: Li, Heng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3n748q6fec5mbdgvaub9g80imm